Manufacturing, Solid and Semi-Solid Dosage Drugs

The companies collaborate to develop and commercialize ARV-471, an investigational oral PROTAC (proteolysis targeting chimeras) estrogen receptor protein degrader.

The F30i double rotary tablet press from Fette Compacting is the second of its new i Series.

CPI has revealed an agreement with DFE Pharma, making it the latest partner of the Medicines Manufacturing Innovation Centre (MMIC) collaboration.

Consider best practices for manual or clean-in-place procedures.

Researchers from the United Kingdom, have identified a new additive manufacturing method that enables the 3D printing of medicine in highly porous structures.

Aprecia and Glatt investigate manufacturing technologies to widen the formulation design space for oral delivery.

Intensified and distributed manufacturing approaches create flexible, local capacity.

Manufacturers of oral solid dose pharmaceutical formulations need PAT tools to reduce a product’s time-to-market and increase profitability.

Tests evaluated commercial rotary tablet presses to see how effectively they deal with problems such as poor flow, overlubrication, and capping.

Understanding difficulties that can occur during manufacture and resolving them quickly can improve oral solid-dosage drug production.

Aprecia's compression-free 3DP manufacturing platform and Glatt’s multiparticulate technologies offer solutions to pharmaceutical dosage design challenges.

Advanced manufacturing technologies are available, but challenges need to be addressed.

The new division will provide system solutions and individual machines and components.

The first of its kind, Lycagel is made up of pea starch technology.

The OneXpress solution is designed to accelerate oral dosage drug development and manufacturing.

CMDO Piramal Pharma Solutions held a grand opening at a facility they acquired in Sellersville, PA.

The renovations are expected to be completed by Feb. 1, 2021 and, upon completion, Aphena will move its corporate headquarters to the new location.

The $10 million expansion, which will be completed and fully operational by February 2021, will add on 3760 square feet of production space.

Early adopters and equipment manufacturers refine their equipment and processes, paving the way for broader use.

Data and software identify optimum pharmaceutical packaging choices for the required shelf-life.

Using a specific addition method to wet the powder bed in twin-screw granulation using a foam binder improves robustness for continuous solid-dosage drug product manufacturing.

Real-time monitoring and the principles of quality by design were used to optimize an OSD coating process.

The continuous manufacturing platform can be used for individual unit operations or a complete solid-dosage manufacturing line and can be integrated with third-party equipment.

The facility has dedicated manufacturing and packaging for oral solid dosage forms, liquids, creams, and ointments.

Under the terms of the agreement, Catalent will develop a powder-in-capsule formulation of Ennaid’s ENU200 program at its site in San Diego, CA.